The Ministry of AYUSH has approved a proposal for carrying out a clinical study to assess the role of Vasa and Guduchi in the therapeutic management of symptoms in COVID-19 positive patients. The randomized, open-label three-armed study will be conducted at the All India Institute of Ayurveda (AIIA), New Delhi, in collaboration with the CSIR-IGIB.
Vasa and Guduchi are time-tested herbs in Indian healthcare traditions, used in a variety of disease conditions. The study would look into the efficacy/action of mono-herbal formulations of whole extracts of Vasa and Guduchi respectively, and polyherbal formulation of Vasa-Guduchi whole extract on therapeutic management of SARS-CoV-2 positive asymptomatic and/or mild COVID-19 symptomatic cases. The project will also assess the impact of the formulations on the speed of viral replication.